Author

Désirée Schnidrig

University of BernORCID 0000-0002-7947-7666Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Organism:mouse· 1 Assay:spatial transcriptomics· 1 Approach:statistical model· 1 Research Focus:variant calling· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Andrej BenjakiD· 2 shared Charlotte K.Y. NgiD· 2 shared Andrea GarofoliiD· 1 shared Bruno CogliatiiD· 1 shared Federico Di TullioiD· 1 shared Gunnar RätschiD· 1 shared Jan S. TchorziD· 1 shared Joana I. Almeida· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Andrej BenjakORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Liver Zonation Disruption Fuels Hepatocellular Carcinoma in Chronic Liver Disease

Sue Bin Yang, Federico Di Tullio, Lida Yang, Bruno Cogliati, Désirée Schnidrig, Andrej Benjak, Shamsa Roshan, Joana I. Almeida, Lilian Yanqing Li, Sai Ma, Jan S. Tchorz, Charlotte K.Y. Ng, Tianliang Sun

This study identifies zonation disruption, specifically aberrant β-catenin expansion, as a novel driver of hepatocellular carcinoma in chronic liver disease, revealing a distinct human HCC subtype with therapeutic implications.

bioRxiv · Dec 10, 2025 · PreprintCancer Biology

PipeIT2: A tumor-only somatic variant calling workflow for Molecular Diagnostic Ion Torrent sequencing data

Désirée Schnidrig, Andrea Garofoli, Andrej Benjak, Gunnar Rätsch, Mark A. Rubin, Salvatore Piscuoglio, Charlotte K.Y. Ng

PipeIT2 is a somatic variant calling workflow for Ion Torrent sequencing data that identifies mutations without germline control, achieving >95% recall for variants with >10% allele fraction.

Genomics · Feb 14, 2023Peer-reviewedBioinformatics